** HealthEquity's HQY.O shares down 14% premarket to $87.50, over four-mth low, after health-savings account (HSA) manager's mixed qtrly results, disappointing forecast
** HQY shares on course for biggest one-day pct decline in two years, if losses hold
** Draper, Utah-based co late Tues posted Q4 rev growth of 19% y/y to $311.8 mln and adj EPS of 69 cents. Consensus called for rev of $306.1 mln and earnings of 72 cents, per LSEG
** On the earnings call, co said gross profit and margins in qtr impacted by ~$17 mln of additional service costs around cybersecurity and fraud prevention
** For FY26, it projected rev of $1.28-$1.31 bln and adj EPS of $3.57-$3.74. The midpoints of both ranges were below what analysts had anticipated
** Co said it added a record one million new HSAs in FY25 to nearly 10 mln as of Jan 31, up 14% from last year, with total assets in those accounts of $32.1 bln, a 27% y/y increase
** Of 14 analysts covering HQY, recommendation breakdown is 13 "strong buy" or "buy" and 1 "hold"'; median PT is $116 - LSEG data
** Through Tues close, stock up 6% YTD and up ~23% over the past 12 months
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。